Author

Yvette Kazungu

Liverpool School of Tropical MedicineORCID 0000-0002-5589-5804Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Amy E. MarriottiD· 1 shared Andrew SteveniD· 1 shared Anja KipariD· 1 shared James P. StewartiD· 1 shared Jessica L DagleyiD· 1 shared Jesús ReinéiD· 1 shared Joseph D. TurneriD· 1 shared Matthias MackiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Amy E. MarriottORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyVirulencePeer-reviewedJul 15, 2026

The CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19

Yvette Kazungu, Shrilakshmi Hegde, Parul Sharma…·Joseph D. Turner

This study shows that targeting the CCR2 inflammatory pathway reduces severe disease and pulmonary inflammation in a mouse model of SARS-CoV2 infection.

DOI 10.1080/21505594.2026.2690741

mousebulk RNA-seq

𝕏 PostBluesky